At the Dutch Medicines Days (DMD), the Galen awards have been presented. Led by a jury, these awards are presented anually to one researcher and one drug that is the most innovative and meaningful. This year’s best researcher was Tom Würdinger, PhD of the neuro-oncology group at the VUmc, Amsterdam. The award for the best drug went to Kalydeco from Vertex, a compound indicated for cystic fibrosis (CF). Continue reading
Showing articles tagged with 'Vertex'